The NIH defines women’s health research as the study of diseases unique to women (such as breast cancer), or diseases with a higher prevalence in women than in men (such as osteoporosis), or diseases that present differently in women than in men (such as heart disease). Continued research and treatments are needed in this important area, like the clinical trials conducted by ProTrials, to help to further improve patients’ lives.

As a WBENC-certified 100% woman owned CRO, ProTrials is dedicated to advancing women’s health. Our team has deep experience in the management and monitoring of related trials. Our knowledge encompasses a range of indications, including work in all phases of drug development as well as device trials. Trial sizes range from 1 to 80+ sites and 60 to 700+ subjects globally. Whatever the size or indication, our goal is to be the women’s health CRO of choice for sponsors internationally.